| High-throughput mapping of B cell receptor sequences to antigen specificity I Setliff, AR Shiakolas, KA Pilewski, AA Murji, RE Mapengo, K Janowska, ... Cell 179 (7), 1636-1646. e15, 2019 | 241 | 2019 |
| Prior infection with SARS-CoV-2 boosts and broadens Ad26. COV2. S immunogenicity in a variant-dependent manner R Keeton, SI Richardson, T Moyo-Gwete, T Hermanus, MB Tincho, ... Cell host & microbe 29 (11), 1611-1619. e5, 2021 | 107 | 2021 |
| SARS-CoV-2 Omicron triggers cross-reactive neutralization and Fc effector functions in previously vaccinated, but not unvaccinated, individuals SI Richardson, VS Madzorera, H Spencer, NP Manamela, ... Cell Host & Microbe 30 (6), 880-886. e4, 2022 | 93 | 2022 |
| HIV-specific Fc effector function early in infection predicts the development of broadly neutralizing antibodies SI Richardson, AW Chung, H Natarajan, B Mabvakure, NN Mkhize, ... PLoS pathogens 14 (4), e1006987, 2018 | 81 | 2018 |
| IgG3 enhances neutralization potency and Fc effector function of an HIV V2-specific broadly neutralizing antibody SI Richardson, BE Lambson, AR Crowley, A Bashirova, C Scheepers, ... PLoS pathogens 15 (12), e1008064, 2019 | 76 | 2019 |
| Hinge length contributes to the phagocytic activity of HIV-specific IgG1 and IgG3 antibodies TH Chu, AR Crowley, I Backes, C Chang, M Tay, T Broge, M Tuyishime, ... PLoS pathogens 16 (2), e1008083, 2020 | 70 | 2020 |
| Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functions AR Shiakolas, KJ Kramer, D Wrapp, SI Richardson, A Schäfer, S Wall, ... Cell Reports Medicine 2 (6), 2021 | 61 | 2021 |
| SARS-CoV-2 Beta and Delta variants trigger Fc effector function with increased cross-reactivity SI Richardson, NP Manamela, BM Motsoeneng, H Kaldine, F Ayres, ... Cell Reports Medicine 3 (2), 2022 | 51 | 2022 |
| Novavax NVX-COV2373 triggers neutralization of Omicron sub-lineages JN Bhiman, SI Richardson, BE Lambson, P Kgagudi, N Mzindle, ... Scientific reports 13 (1), 1222, 2023 | 41 | 2023 |
| The continuous evolution of SARS-CoV-2 in South Africa: a new lineage with rapid accumulation of mutations of concern and global detection C Scheepers, J Everatt, DG Amoako, A Mnguni, A Ismail, B Mahlangu, ... Medrxiv, 2021 | 40 | 2021 |
| Measuring the ability of HIV-specific antibodies to mediate trogocytosis SI Richardson, C Crowther, NN Mkhize, L Morris Journal of immunological methods 463, 71-83, 2018 | 36 | 2018 |
| Ad26. COV2. S breakthrough infections induce high titers of neutralizing antibodies against Omicron and other SARS-CoV-2 variants of concern D Kitchin, SI Richardson, MA van der Mescht, T Motlou, N Mzindle, ... Cell Reports Medicine 3 (3), 2022 | 34 | 2022 |
| V2-directed vaccine-like antibodies from HIV-1 infection identify an additional K169-binding light chain motif with broad ADCC activity C van Eeden, CK Wibmer, C Scheepers, SI Richardson, M Nonyane, ... Cell reports 25 (11), 3123-3135. e6, 2018 | 31 | 2018 |
| Emergence and phenotypic characterization of the global SARS-CoV-2 C. 1.2 lineage C Scheepers, J Everatt, DG Amoako, H Tegally, CK Wibmer, A Mnguni, ... Nature Communications 13 (1), 1976, 2022 | 28 | 2022 |
| Emergence and phenotypic characterization of C. 1.2, a globally detected lineage that rapidly accumulated mutations of concern C Scheepers, J Everatt, DG Amoako, H Tegally, CK Wibmer, A Mnguni, ... MedRxiv, 2021.08. 20.21262342, 2021 | 28 | 2021 |
| Common helical V1V2 conformations of HIV-1 Envelope expose the α4β7 binding site on intact virions CK Wibmer, SI Richardson, J Yolitz, C Cicala, J Arthos, PL Moore, ... Nature communications 9 (1), 4489, 2018 | 27 | 2018 |
| South African HIV-1 subtype C transmitted variants with a specific V2 motif show higher dependence on α4β7 for replication SI Richardson, ES Gray, NN Mkhize, DJ Sheward, BE Lambson, ... Retrovirology 12, 1-16, 2015 | 27 | 2015 |
| Targeting Fc effector function in vaccine design SI Richardson, PL Moore Expert Opinion on Therapeutic Targets 25 (6), 467-477, 2021 | 19 | 2021 |
| Antibody isotype switching as a mechanism to counter HIV neutralization escape C Scheepers, V Bekker, C Anthony, SI Richardson, B Oosthuysen, T Moyo, ... Cell reports 33 (8), 2020 | 17 | 2020 |
| Durability of ChAdOx1 nCoV-19 (AZD1222) vaccine and hybrid humoral immunity against variants including omicron BA. 1 and BA. 4 6 months after vaccination (COV005): a post-hoc … SA Madhi, G Kwatra, SI Richardson, AL Koen, V Baillie, CL Cutland, ... The Lancet Infectious Diseases 23 (3), 295-306, 2023 | 16 | 2023 |
